Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations - Milan 2023

Development and treatment of severe asthma

Chair(s): Carmen Cornelia Maria de Jong, Eckard Hamelmann

Session type: Poster session

Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations

Eckard Hamelmann

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Severe asthma (SA) in children: data from the Italian society for paediatric respiratory diseases (SIMRI) database

Silvia Carraro

Poster

Abstract

Adherence to inhaled steroids in children on asthma biologics; prescription uptake for inhaled steroids in children treated with asthma biologic therapy.

Susan Frost

Poster

Abstract

Predicting aerosol deposition in children with severe asthma and small airways disease

Harm Tiddens

Poster

Abstract

Blood hypereosinophilia in childhood asthma: impact on disease severity

Besma Hamdi

Poster

Abstract

Association between airway dimension, the clinical severity of bronchiolitis and the development of pre-school wheezing

Greta Di Mattia

Poster

Abstract

Ezrin: potential biomarker of airway epithelial repair and wheeze morbidity in children

Thomas Iosifidis

Abstract

Factors associated with severe asthma exacerbation in children

Besma Hamdi

Poster

Abstract

Portable oscillometry in preschool children attending the Emergency Department with wheezing

Senali Y Seneviratne

Poster

Abstract

Impedance and spirometry measurements compared in paediatric outpatients with recurrent respiratory symptoms

Maria Cristina Mazzuca

Poster

Abstract

Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for Omalizumab: a single centre experience

Yu Ting Lim

Poster

Abstract

Elevated Neutrophil-to-Lymphocyte ratio is associated with severe asthma exacerbation in children

Noga Arwas

Poster

Abstract

Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations

Eckard Hamelmann

Poster

Abstract

Long-term dupilumab effect on lung function in paediatric patients with uncontrolled asthma

Leonard Bacharier

Poster

Abstract

Dupilumab improves lung function responder rates in children with type 2 asthma in the VOYAGE study

Theresa Guilbert

Poster

Abstract

Comparing functional surrogacy in the upper and lower airway epithelium

Thomas Iosifidis

Abstract

A retrospective multi-center chart review study on the timely administration of systemic corticosteroids in children with moderate-to-severe asthma exacerbations

Luna Antonino

Poster

Abstract

A real-life study on children with severe asthma starting biologicals: results of the PANDA study

Yoni Van Dijk

Poster

Abstract

Asthma exacerbations in severe asthmatic children: Association with clinical scores, FeNO and lung function.

Maria Belen Lucero

Poster

Abstract

The soluble form of the receptor for advanced glycation end products (sRAGE) in infants with first and recurrent episodes of wheezing in correlation with lung ultrasound findings

Polina Shahid

Poster

Abstract

PEDIATRIC SEVERE ASTHMA: HIGH-RESOLUTION CT FEATURES

Amelia Licari

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}